Immunostaining in the context of loss mismatch repair function: interpretive confounders and cautionary tales!

1. Nielsen GP. Lipomatosis. In Fletcher CDM, Unni K, Mertens F eds. Pathology and genetics of tumours of soft tissue and bon. Lyon: IARC Press, 2000; 23–24. 2. Italiano A, Bianchini L, Keslair F et al. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int. J. Cancer 2008; 122; 2233–2241. 3. Ashar HR, Fejzo MS, Tkachenko A et al. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 1995; 82; 57–65. 4. Battista S, Fidanza V, Fedele M et al. The expression of a truncated hmgi-c gene induces gigantism associated with lipomatosis. Cancer Res. 1999; 59; 4793–4797. 5. Zhou X, Benson KF, Ashar HR, Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor hmgi-c. Nature 1995; 376; 771–774. 6. Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007; 21; 1025–1030. 7. Bianchini L, Saada E, Gjernes E et al. Let-7 microRNA and HMGA2 levels of expression are not inversely linked in adipocytic tumors: analysis of 56 lipomas and liposarcomas with molecular cytogenetic data. Genes Chromosomes Cancer 2011; 50; 442–455.